Get the Stockscreener App
1.02
2.94%
0.0291
After Hours:
1.05
0.03
+2.94%
Metavia Inc stock is traded at $1.02, with a volume of 119.80K.
It is up +2.94% in the last 24 hours and up +46.57% over the past month.
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$0.9909
Open:
$0.97
24h Volume:
119.80K
Relative Volume:
0.08
Market Cap:
$24.68M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.77%
1M Performance:
+46.57%
6M Performance:
-44.57%
1Y Performance:
+0.00%
1-Day Range:
$0.9513
$1.02
1-Week Range:
$0.9501
$1.10
52-Week Range:
$0.5555
$2.75
Metavia Inc Stock (MTVA) Company Profile
Name
Metavia Inc
Sector
Industry
Phone
(857) 702-9600
Address
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
1.02 | 23.98M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | H.C. Wainwright | Buy |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
Metavia Inc Stock (MTVA) Latest News
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference - Stock Titan
Ranking MetaVia Inc. among high performing stocks via tools2025 Investor Takeaways & Target Return Focused Picks - newser.com
Can momentum traders help lift MetaVia Inc.Weekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
How to forecast MetaVia Inc. trends using time series2025 Investor Takeaways & Community Consensus Trade Signals - newser.com
What analysts say about MetaVia Inc stockTechnology Stock Trends & High Return Investment Ideas - earlytimes.in
What candlestick patterns are forming on MetaVia Inc.Rate Hike & Safe Entry Point Alerts - newser.com
Evaluating MetaVia Inc. with trendline analysisJuly 2025 Analyst Calls & Proven Capital Preservation Methods - newser.com
Measuring MetaVia Inc.’s beta against major indicesJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Applying chart zones and confluence areas to MetaVia Inc.Portfolio Gains Report & Community Driven Trade Alerts - newser.com
How to integrate MetaVia Inc. into portfolio analysis toolsJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
MetaVia Inc. stock trend forecastWeekly Profit Summary & Free Weekly Watchlist of Top Performers - newser.com
Building trade automation scripts for MetaVia Inc.2025 Technical Overview & Smart Investment Allocation Insights - newser.com
What drives MetaVia Inc stock priceAnalyst Downgrades & Avoid Market Traps With Pro-Level Warnings - earlytimes.in
Applying Elliott Wave Theory to MetaVia Inc.Share Buyback & Safe Swing Trade Setups - newser.com
Can swing trading help recover from MetaVia Inc. lossesQuarterly Performance Summary & Reliable Price Breakout Signals - newser.com
Price action breakdown for MetaVia Inc.Trade Volume Summary & Advanced Technical Analysis Signals - newser.com
Westpark Capital Maintains MetaVia(MTVA.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Is Direxion Emerging Markets Bear 3X stock undervalued historicallyNew Guidance & Safe Entry Momentum Tips - newser.com
Will Diana Shipping Inc. (DSZ) stock outperform foreign stocks2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Will MAYZ stock gain from lower interest rates2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Is a relief rally coming for The InterGroup Corporation holdersJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - newser.com
Key resistance and support levels for MetaVia Inc.Quarterly Investment Review & Weekly Hot Stock Watchlists - newser.com
How moving averages guide MetaVia Inc. tradingJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Chart based analysis of MetaVia Inc. trendsWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
Risk adjusted return profile for MetaVia Inc. analyzedJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com
MetaVia Inc. stock retracement – recovery analysisJuly 2025 Rallies & High Yield Stock Recommendations - newser.com
Advanced analytics toolkit walkthrough for MetaVia Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Can a trend reversal in MetaVia Inc. lead to recoveryLayoff News & Free Weekly Chart Analysis and Trade Guides - newser.com
Aug PostEarnings: Will MetaVia Inc stock go up in YEARInflation Watch & Free Technical Pattern Based Buy Signals - خودرو بانک
Forecasting MetaVia Inc. price range with options data2025 Top Gainers & High Yield Stock Recommendations - newser.com
Metavia Inc Stock (MTVA) Financials Data
There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metavia Inc Stock (MTVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DONG-A ST CO., LTD | 10% Owner |
May 08 '25 |
Buy |
0.71 |
4,647,887 |
3,300,000 |
9,995,679 |
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):